GlassScriptPhysician profile
Michael J Klebuc
NPI 1225067887
$203,892.16
in general payments reported to CMS, 2019-2025
17 companies · $391 in 2025
The $391 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200K · 2020: $255 · 2021: $302 · 2022: $651 · 2023: $1,197 · 2024: $680 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,258 · Travel and Lodging: $10.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,257.76 |
| Travel and Lodging | $10.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $200,036.26 | 2019-2024 | Perclot |
| Mentor Worldwide LLC | $651.17 | 2020-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Allergan, INC. | $577.84 | 2019-2022 | |
| Abbvie INC. | $568.17 | 2021-2025 | |
| Davol INC. | $269.62 | 2022 | |
| Depuy Synthes Sales INC. | $240.85 | 2023-2025 | Matrixcombo, Matrixmandible |
| Axogen | $237.40 | 2019-2025 | |
| Medtronic, INC. | $224.94 | 2022-2024 | V-Loc 180, Midas Rex |
| Alafair Biosciences, INC. | $187.17 | 2022-2023 | Versawrap |
| Integra Lifesciences Corporation | $146.65 | 2023 | Durasorb Monofilament Mesh |
| Kerecis Limited | $142.61 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Musculoskeletal Transplant Foundation INC. | $135.02 | 2023 | |
| Zimmer Biomet Holdings, INC. | $115.38 | 2019 | |
| Sientra, INC. | $107.71 | 2019 | |
| Vioptix INC | $107.51 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $106.75 | 2019-2023 | Checkpoint Stimulators |
| Pacira Pharmaceuticals Incorporated | $37.11 | 2023 | Iovera, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Klebuc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.